Crospon logo

Home
About Us
Product Brochures
EndoFLIP® Technology

Clinical Applications

- Upper GI Surgery

- Bariatric Surgery

- Upper GI Imaging

- Cardiology

- Therapeutic Endoscopy

- Colorectal Imaging

Distributors
Newsroom
Events
Awards
Contact Us



 

 

Crospon receives expanded indications from FDA for EsoFLIP® Dilation Catheter

Product launch of ES-320 Dilator to take place in October at the American College of Gastroenterology 2014 Annual Scientific Meeting in Philadelphia

29th September 2014

Crospon has today announced that it has received clearance from the US FDA for expanded indications of use for its EsoFLIP® balloon dilation catheter line. The new ES-320 dilation catheter is used for dilation of esophageal strictures due to esophageal surgery, gastro-esophageal reflux and radiation therapy. The product will be launched in October at the American College of Gastroenterology 2014 Annual Scientific Meeting in Philadelphia.

Commenting on the FDA clearance, John O'Dea, CEO, Crospon said, "This product clearance permits Crospon to participate in a significantly larger market segment than that of our previously announced ES-330 achalasia dilator. It represents our continued commitment to innovation and to expanding our product folio beyond the EndoFLIP gastrodiagnostic platform for which five US patents have issued in 2014."

Download pdf Press Release

 

 
Newsroom Links
News Headlines
Upcoming Events
         
EndoFLIP logo   Crospon (USA) 701 Palomar Airport Rd, Carlsbad, CA 92011, USA. Phone: 1-855-CROSPON
Crospon (EU) Galway Business Park, Dangan, Galway, H91 P2DK, Ireland. Phone +353-91-519880